IMV Inc. (IMVIF)
USD 0.0
(-50.0%)
USD 0.0
(-50.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 | -36.48 Million USD | -0.6% |
| 2021 | -36.26 Million USD | -32.19% |
| 2020 | -27.43 Million CAD | -30.01% |
| 2019 | -21.1 Million CAD | -31.4% |
| 2018 | -16.06 Million USD | -67.31% |
| 2017 | -9.59 Million USD | -44.7% |
| 2016 | -6.63 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 Q4 | -8.64 Million USD | -2.49% |
| 2022 FY | -36.48 Million USD | -0.6% |
| 2022 Q1 | -10.65 Million USD | 8.62% |
| 2022 Q2 | -9.82 Million USD | 7.79% |
| 2022 Q3 | -8.43 Million USD | 14.17% |
| 2021 Q3 | -10.36 Million USD | 0.0% |
| 2021 FY | -36.26 Million USD | -32.19% |
| 2021 Q4 | -11.65 Million USD | -12.43% |
| 2020 FY | -27.43 Million CAD | -30.01% |
| 2019 FY | -21.1 Million CAD | -31.4% |
| 2018 FY | -16.06 Million USD | -67.31% |
| 2017 FY | -9.59 Million USD | -44.7% |
| 2016 FY | -6.63 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | -2632.129% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -422.505% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 168.868% |
| Nascent Biotech, Inc. | -2.08 Million USD | -1647.665% |
| Rebus Holdings, Inc. | -1.02 Million USD | -3477.029% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 156.017% |
| Qrons Inc. | -789.34 Thousand USD | -4522.263% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -5669.337% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 41.715% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -8681.598% |
| Skye Bioscience, Inc. | -37.64 Million USD | 3.079% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 51.328% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -454.822% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -13245.072% |
| SQZ Biotechnologies Company | -79.46 Million USD | 54.085% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -1161.436% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -1904.127% |
| Mesoblast Limited | -87.95 Million USD | 58.518% |
| Marizyme, Inc. | -65.34 Million USD | 44.166% |
| Genus plc | 7.9 Million USD | 561.844% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -234.985% |
| Pharming Group N.V. | -10.54 Million USD | -245.902% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -1581.513% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -883.38% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -312.547% |
| ContraFect Corporation | -65.15 Million USD | 44.0% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -646.73% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -2012.107% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -352.694% |
| MultiCell Technologies, Inc. | -380.07 USD | -9599630.05% |
| ONE Bio Corp. | 8.67 Million USD | 520.506% |
| Accustem Sciences Inc. | -3.74 Million USD | -873.882% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 29.417% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -2779.387% |
| Q BioMed Inc. | -2.05 Million USD | -1677.975% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -877.383% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -1432.452% |
| Biomind Labs Inc. | -1.21 Million USD | -2904.622% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 38.911% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -1076.287% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -361.663% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -1771.782% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -243527.764% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | -129.883% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -527.198% |
| GB Sciences, Inc. | -1.36 Million USD | -2579.468% |
| Alpha Cognition Inc. | -13.77 Million USD | -164.916% |
| HST Global, Inc. | -146.21 Thousand USD | -24854.308% |
| CSL Limited | 2.64 Billion USD | 101.381% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -1979.228% |
| Halberd Corporation | -79.67 Thousand USD | -45692.577% |
| Enzolytics Inc. | -2.17 Million USD | -1576.091% |
| Agentix Corp. | -1.37 Million USD | -2555.029% |
| Resverlogix Corp. | -3.61 Million USD | -910.684% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -1050.447% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 87.634% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 37330.3% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 626.9% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -818.343% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -1105.686% |
| AVAX Technologies, Inc. | -6.41 Million USD | -468.876% |
| Zenith Capital Corp. | -10.59 Million USD | -244.335% |
| Genscript Biotech Corporation | -95.47 Million USD | 61.786% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -156881.731% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -780.035% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -60266.191% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -1719.631% |
| Kadimastem Ltd | -3.3 Million USD | -1003.154% |
| Helix BioMedix, Inc. | -1.05 Million USD | -3354.898% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -855.373% |
| BioStem Technologies, Inc. | -8.48 Million USD | -330.104% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -8166.483% |
| LadRx Corporation | 400.44 Thousand USD | 9211.333% |
| Cell Source, Inc. | -5.32 Million USD | -585.665% |
| Regen BioPharma, Inc. | 1.02 Million USD | 3664.769% |
| Regen BioPharma, Inc. | 1.02 Million USD | 3664.769% |
| NovAccess Global Inc. | -4.76 Million USD | -665.03% |
| Affymax, Inc. | -14.42 Million USD | -152.951% |
| Itoco Inc. | -1.86 Million USD | -1852.156% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -721.281% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -2086.081% |
| Mobile Lads Corp. | -2.26 Million USD | -1512.063% |
| CytoDyn Inc. | -49.84 Million USD | 26.796% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -46065.139% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -15893.589% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -3775.154% |
| SYBLEU INC | -180.3 Thousand USD | -20135.654% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -2162.346% |
| International Stem Cell Corporation | -131 Thousand USD | -27751.675% |
| Bioxytran, Inc. | -4.28 Million USD | -752.469% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -67127.473% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -1341.982% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 24.102% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -1625.908% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -4572.34% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -1051.695% |
| Neutra Corp. | -233.46 Thousand USD | -15527.907% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -79.812% |
| PureTech Health plc | -65.69 Million USD | 44.464% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | -71.564% |
| IXICO plc | -1.17 Million USD | -2997.258% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -267.54% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 36.133% |
| CSL Limited | 2.64 Billion USD | 101.381% |
| Cellectis S.A. | -103.17 Million USD | 64.637% |